Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666210 · ClinicalTrials.gov registry record · Phase 2
Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
A Phase 2 study of Ocular Inflammation and Pain, sponsored by Ocular Therapeutix.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01666210: Completed Phase 2 study of Ocular Inflammation and Pain, sponsored by Ocular Therapeutix.
NCT01666210 is a Phase 2 study of Ocular Inflammation and Pain that has completed, run by Ocular Therapeutix. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01666210, a Phase 2 study of Ocular Inflammation and Pain, has completed, sponsored by Ocular Therapeutix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of ocular inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.
Conditions Studied
Interventions
- DRUG OTX-DP (Dexamethasone punctum plug)
- DRUG Placebo Vehicle Punctum Plug
Study Locations (1)
Illinois
- Chicago Cornea Consultants, Ltd. - Hoffman Estates
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
What the finished NCT01666210 record still lists
NCT01666210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Ocular Inflammation and Pain appearing as the primary indexed condition, and to 2 interventions - of which OTX-DP (Dexamethasone punctum plug) is the first listed.
NCT01666210 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01666210 about?
NCT01666210 is a clinical study titled "Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery". To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of ocular inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.
What is the current status of trial NCT01666210?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-10. Estimated completion is 2013-08.
What conditions does trial NCT01666210 study?
This clinical trial studies the following conditions: Ocular Inflammation and Pain.
What interventions are being tested in trial NCT01666210?
The interventions under investigation include: OTX-DP (Dexamethasone punctum plug) (DRUG), Placebo Vehicle Punctum Plug (DRUG).
Who is sponsoring clinical trial NCT01666210?
This trial is sponsored by Ocular Therapeutix, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666210 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01666210's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia